Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Pacific Biosciences of California    P09

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
05/22/2017 05/23/2017 05/24/2017 05/25/2017 05/26/2017 Date
3.388(c) 3.349(c) 3.255(c) 3.276(c) 3.239(c) Last
0 0 0 0 0 Volume
-3.06% -1.15% -2.81% +0.65% -1.13% Change
More quotes
Financials ($)
Sales 2017 108 M
EBIT 2017 -86,5 M
Net income 2017 -89,5 M
Debt 2017 0,50 M
Yield 2017 -
Sales 2018 135 M
EBIT 2018 -68,8 M
Net income 2018 -71,7 M
Finance 2018 0,23 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 3,18x
EV / Sales2018 2,53x
Capitalization 342 M
More Financials
Company
Pacific Biosciences of California, Inc. engages in the research, development and manufacture of sequencing systems for genetic analysis.It operates through the following geographical segments: North America, Europe, and Asia.It offers deoxyribonucleic acid sequencing, third generation sequencing... 
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Latest news on PACIFIC BIOSCIENCES OF CAL
05/25 PACIFIC BIOSCIENCES OF CALIFORNIA, I : PACB) Files An 8-K Submission of Matters ..
05/25 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Submission of Matters to a Vote of Securi..
05/25 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Sequencing Reactions with ..
05/22 Recent Publications Demonstrate Rapid Adoption of SMRT Sequencing for Plant a..
05/11 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Charged Triplet-State Quen..
05/05 PACIFIC BIOSCIENCES OF CALIFORNIA : Management's Discussion and Analysis of Fina..
04/28 PACIFIC BIOSCIENCES OF CALIFORNIA : Today's Research Reports on Biotech Stocks t..
04/26 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Results of Operations and Financial Condi..
04/26 PACIFIC BIOSCIENCES OF CALIFORNIA, I : PACB) Files An 8-K Results of Operations ..
04/26 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Results of Operations and Financial Condi..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/17 PHILIPS CEO : uptake of connected care products progressing slowly
05/15DJMARKET SNAPSHOT : Stock Market Sets Fresh Records As Oil Rallies
05/15 Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services
More sector news : Advanced Medical Equipment & Technology - NEC
Advertisement
Chart PACIFIC BIOSCIENCES OF CAL
Duration : Period :
Pacific Biosciences of Cal Technical Analysis Chart | P09 | US69404D1081 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 6,77 $
Spread / Average Target 85%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael W. Hunkapiller Executive Chairman, President & CEO
Susan K. Barnes CFO, Principal Accounting Officer & Executive VP
Stephen W. Turner Chief Technical Officer & Vice President
James Michael Phillips Senior Vice President-Research & Development
Jonas Korlach Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF..-11.41%342
THERMO FISHER SCIENTIF..22.54%67 845
DANAHER CORPORATION8.43%58 584
BOSTON SCIENTIFIC CORP..26.31%37 412
INTUITIVE SURGICAL, IN..43.55%33 538
PHILIPS8.28%32 627
More Results